Nanotherapeutics Revenue and Competitors

Alachua, FL USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Nanotherapeutics's estimated annual revenue is currently $4.8M per year.(i)
  • Nanotherapeutics's estimated revenue per employee is $201,000

Employee Data

  • Nanotherapeutics has 24 Employees.(i)
  • Nanotherapeutics grew their employee count by -20% last year.

Nanotherapeutics's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$26.5M132N/AN/AN/A
#2
$10.1M5014%N/AN/A
#3
$282.6M1406N/AN/AN/A
#4
$13.9M6944%N/AN/A
#5
$11.3M564%N/AN/A
#6
$11.5M57-7%N/AN/A
#7
$211.7M10724%N/AN/A
#8
$24.1M1205%N/AN/A
#9
$7.8M39-2%N/AN/A
#10
$12.9M64-2%N/AN/A
Add Company

What Is Nanotherapeutics?

Nanotherapeutics is a privately-held emerging biopharmaceutical company with both proprietary platform technologies and a diversified pipeline of products. The Company has expertise in pre-clinical and clinical development, formulation optimization, and cGMP manufacturing of biopharmaceutical products and medical devices. The Company's proprietary platform technologies can be used with all drug types, ranging from small molecules to proteins and vaccines. Many of our diversified products have multiple indications ("dual-use") with potential in the areas of infectious diseases, CNS, oncology, vaccines, and biodefense. Over the past several years, we have focused our efforts on meeting the US government's interests to develop safe, effective medical countermeasures against certain biological and radiological threats.

keywords:N/A

N/A

Total Funding

24

Number of Employees

$4.8M

Revenue (est)

-20%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Nanotherapeutics News

2022-04-20 - Global Micro Chemotherapy Market 2022 Growth Parameters ...

Amgen; Celgene; MagForce AG; Nanotherapeutics; Spectrum Pharmaceuticals; Ablynx(Sanofi); AMAG; CytImmune; Delpor; Nanospectra; Merrimack; Tarveda.

2022-04-17 - Micro Chemotherapy Market Size, Scope And Forecast ...

Amgen, Celgene, MagForce AG, Nanotherapeutics, Spectrum Pharmaceuticals, Ablynx, AMAG, CytImmune, Delpor, Nanospectra, Merrimack, Tarveda.

2022-04-13 - Nanotherapeutics for hepatocellular carcinoma treatment

Nanotherapeutics have shed new light onto HCC treatment by enabling site-specific in vivo delivery of chemotherapeutics specifically to...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
N/A26-10%N/A
#2
$3.5M30-6%N/A
#3
$4.8M31-56%N/A
#4
$4.8M31-56%N/A
#5
$5M3210%N/A